Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Omega Therapeutics, Inc. | President and Chief Executive Officer, Director | Stock Option (Right to Buy) | 340K | Nov 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Nov 15, 2024 | 1 | $0 | 4 | Nov 15, 2024 | President and Chief Executive Officer, Director |
OMGA | Omega Therapeutics, Inc. | May 31, 2024 | 1 | $0 | 4 | May 31, 2024 | Chief Business Officer |
OMGA | Omega Therapeutics, Inc. | May 28, 2024 | 0 | $0 | 3 | May 31, 2024 | Chief Business Officer |